Alfa Cytology delivers innovative model platforms that turn in-vitro insights into in-vivo evidence. Our PrimePDX Platform (next-gen PDX for clinical simulation) and Hu-Immune Platform (humanized immune system mouse models) power standardized yet configurable studies for faster, clinically relevant readouts. From target discovery to IND, we provide integrated efficacy, PK, and safety services to accelerate cancer therapeutic development.